Literature DB >> 34251094

STAT3 polymorphisms in North Africa and its implication in breast cancer.

Wafa Ziadi1, Sami Boussetta1, Sarra Elkamel1, Andrew J Pakstis2, Kenneth K Kidd2, Imen Medimegh1, Amel Ben Ammar Elgaaied1, Lotfi Cherni1,3.   

Abstract

BACKGROUND: Only a few studies have investigated the association of single nucleotide polymorphisms in STAT3 gene with the susceptibility to cancer and response to chemotherapy. Our aim was to determine the allele frequencies of rs3869550, rs957971, and rs7211777 at the STAT3 gene in North African populations and compare them to 1000 genomes populations, and to investigate their relation with cancer.
METHODS: The targeted SNPs have been analyzed in six Tunisian populations and a sample of Libyans using TaqMan® Assay. The results were compared to 1000 Genomes Project population samples. Targeting of the regions encompassing the three SNPs by micro-ARN was assessed using miR databases.
RESULTS: The analysis of the 3 SNPs showed that North African populations were close to South Asians. As expected, African populations presented a significant frequency of the ancestral CCG haplotype in contrast to other populations where the fully derived TGA haplotype was more frequent. The presence and diversity of rare haplotypes at STAT3 in North African populations could have been generated by recombination between the two major haplotypes. A screening of the micro-RNA databases showed that the STAT3 region with the mutated allele of rs7211777 (G>A) could be targeted by miR hsa-miR-3606-5p, which also targets genes involved in breast cancer.
© 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.

Entities:  

Keywords:  zzm321990STAT3zzm321990; North Africa; breast cancer; miR-3606-5p; rs7211777

Mesh:

Substances:

Year:  2021        PMID: 34251094      PMCID: PMC8404238          DOI: 10.1002/mgg3.1744

Source DB:  PubMed          Journal:  Mol Genet Genomic Med        ISSN: 2324-9269            Impact factor:   2.183


INTRODUCTION

Signal transducer and activator of transcription protein 3 (STAT3) (OMIM accession number: *102582) is encoded by one of seven STAT family genes located in chromosomal band 17q21.2 and extends over 75kb (Aggarwal et al., 2009). Its expression is induced by cytokines, hormones, and growth factors. STAT3 protein is activated by phosphorylation of its tyrosine and serine residues via signaling from upstream regulators (Klemm et al., 1998). STAT3 is reported to regulate the expression of many genes such as Bcl‐xL, cyclin D1, c‐myc, VEGF, IL‐10, IL‐2, subsequently leading to cellular proliferation and slowing‐down of apoptosis (Herrmann et al., 2010; Rane & Reddy, 2000). Moreover, experimental models revealed important immune functions for STAT3, including innate and adaptative immunity (Hillmer et al., 2016). In addition to its physiological role, studies have revealed the role of STAT3 in diseases. Indeed, some mutations in the STAT3 gene are associated with human immune disorders (Gutiérrez et al., 2018; Milner et al., 2015; Velayos et al., 2017). STAT3 is also implicated in tumorigenesis by enhancing tumor growth, survival, invasion, immune suppression, and angiogenesis on the one hand and, decreasing tumor cell apoptosis on the other hand. Moreover, the Jak‐STAT3 signaling pathway has been shown to have central roles in obesity (Priceman et al., 2013) and/or metabolism and in inflammation‐mediated cancer, including cancer stem cells (CSCs) (Schroeder et al., 2014) and pre‐metastatic niche formation (Deng et al., 2012). In fact, many proteins whose expression is driven by overexpression of unphosphorylated STAT3 have been implicated in many cancers (Yang et al., 2005). Activated STAT3 has been implicated in multiple human cancers including lung (Du et al., 2012), gastric (Wu et al., 2012), ovarian, breast (Hsieh et al., 2005) (Sansone et al., 2007), colon (Calon et al., 2012) (Liang et al., 2013), prostate (Kroon et al., 2013), hepatocellular carcinoma (Hatziapostolou et al., 2011), and lymphoma (Liu et al., 2012). A fundamental role for STAT3 in the normal development of the mammary gland and the pathogenesis of human breast cancer (BC) has been established (Clevenger, 2004; Watson, 2001). Several studies have demonstrated increased levels of STAT3 in primary mammary tumors. Immunohistochemical approaches in humans have found increased levels of nuclear‐localized STAT3 in malignant BCs when compared with normal tissues (Watson, 2001). A recent study has identified that STAT3 expression was found to have a significantly higher correlation with luminal breast cancer (Eroglu et al., 2020). Hence, according to these data and because of its implication in cancer development and progression, Signal transducer and activator of transcription protein 3 (STAT3), has been recognized as a type of oncogene (Bromberg et al., 1999). Despite the identification of around fifteen single nucleotide polymorphisms (SNPs) in the STAT3 gene, only a few studies have investigated the association of SNPs in this gene with the susceptibility to cancer. For example, Vaclavicek et al. (2007) reported that the STAT5B rs6503691 and the STAT3 rs7211777 polymorphisms were associated with an increased risk for breast cancer in German patients with familial breast cancer (Vaclavicek et al., 2007). Wang et al. (2011) detected an association between STAT3 polymorphism rs4769793 and cervical cancer. Indeed, women with a G allele appeared to have a higher risk for cervical cancer. Further, the G allele was associated with poor tumor differentiation and positive parametrial invasion (Wang et al., 2011). Moreover, Jiang et al. (2011) have shown that a haplotype in the STAT3 gene may have a protective role in the development of non‐small cell lung cancer (NSCLC) (Jiang et al., 2011). Hence, Zhao et al. (2015) proposed that STAT3 polymorphisms might be a candidate pharmacogenomic factor to assess susceptibility and prognosis of cancer (Zhao et al., 2015). Moreover, it has been shown that rs957971 polymorphism in STAT3 gene may predict an unfavorable response to first‐line platinum‐based therapy for women with advanced serous epithelial ovarian cancer in an American population sample of European ancestry (Permuth‐Wey et al., 2016). In the present study, we characterized the genetic variation of STAT3 gene in Tunisian and Libyan populations. The association status of STAT3 polymorphism and cancer in Tunisian populations is still unknown. Only two case/control studies on STAT3 polymorphism have been conducted in these populations. The first on rs744166, in Pemphigus patients, with no association was carried out (Ben Jmaa et al., 2018), and the second on rs1053023 and rs1053004 in relation to the Idiopathic Recurrent Miscarriage (IRM) showing that STAT3 rs1053023 was positively associated with IRM in Tunisian women (Messoudi et al., 2013). In this paper, we focused on two single nucleotide polymorphisms rs7211777 (g.42382057G>A) and rs3869550 (g.42340869T>C), chosen for their association with cancer in German and Chinese populations (Jiang et al., 2011; Vaclavicek et al., 2007). In addition to these two SNPs, we also investigated rs957971 (g.42367907C>G), located in the STAT3 gene between these two SNPs; rs957971 has been associated with the response to chemotherapy (Permuth‐Wey et al., 2016). Results will be discussed according to haplotypic diversity in this gene among North African populations.

MATERIALS AND METHODS

Ethical compliance

This work is approved by Ethics Committee for Research in Life Sciences and Health of the ISBM (CER‐SVS/ISBM).

DNA samples and STAT3 SNP typing

A total of 349 North African individuals were collected including 279 Tunisians from 6 populations well distributed throughout Tunisia: Kesra (n = 42) to the north, Sousse (n = 46), Mahdia (n = 45) and Kairouan (n = 40) to the center, Smar (n=62) to the south, and a population of Kerkennah island (n = 44), in addition to 70 Libyans (Figure 1). All individuals sampled were unrelated and healthy persons and all individuals gave informed consent for the study of DNA sequence variants.
FIGURE 1

Localization of the seven North African populations analyzed in this study

Localization of the seven North African populations analyzed in this study Total human genomic DNA was isolated from peripheral blood samples collected into EDTA tubes using the phenol‐chloroform method. The 3 SNPs (rs3869550, rs957971, rs7211777) of the STAT3 gene have been typed in 3 μl reactions using TaqMan® Assay‐on‐demand following the manufacturer's protocol. Assays were obtained from Applied Biosystems, Thermo Fisher AB TaqMan Catalog Numbers C___7530575_10 C___1952199_10 C___1952182_10, respectively. 384‐well plates were read on an AB7900 thermocycler using SDS software. The SNP frequency results are in Appendix Table A; see also the ALFRED database (Cherni et al., 2016; Rajeevan et al., 2012) at https://alfred.med.yale.edu. The Reference sequence gene of STAT3 is: RefSeqGene (LRG_112) on chromosome 17 (Accession NG_007370, Region: 5001..80171, Version NG_007370.1).

Statistical analysis

The analysis of allelic and genotypic frequencies was performed using Plink 1.09 software (Purcell et al., 2007) http://pngu.mgh.harvard.edu/purcell/plink/, and the calculation of haplotypes has been done with the HAPLO program (Hawley & Kidd, 1995) based on the EM algorithm (Dempster et al., 1977). The determination of linkage disequilibrium (LD) between the studied SNPs was performed with Haploview Software for all the North African populations. For comparative analysis, we included data from 59 populations from the Kidd Lab (Brissenden et al., 2015; Cherni et al., 2016) and the 26 worldwide populations from The 1000 Genomes Project (1KG) (Consortium, 2015). The haplotypic data of the three SNPs were downloaded from LD link website of the 1000 Genome Project (Machiela & Chanock, 2015). Data obtained from the 7 North African populations analyzed in this study were merged with data from the 1KG project subset (Table S1: Population list file, supplementary material). Principal Component Analysis (PCA) was performed with PAST software (Hammer et al., 2001).

miRNA targeting STAT3 mRNA

On the STAT3 gene, the three studied SNPs are intronic; rs7211777 and rs957971 are in intron 1 and rs3869550 is in intron 4 (Figure 2). Both normal genomic sequences and those carrying the derived STAT3 allele were investigated. MiRs targeting the areas with the studied SNPs were identified using the online database miRBase. The investigated sequences cover 50 nucleotides on each side of the studied SNP. This was done by transporting a 100 bp sequence containing the ancestral and derived genotype of the SNP studied in the search application of the miRBase site: http://www.mirbase.org/index.shtml.
FIGURE 2

SNPs (rs7211777, rs957971, rs3869550) positions on STAT3

SNPs (rs7211777, rs957971, rs3869550) positions on STAT3 Expression information on the identified miRNA and its relationship with breast cancer was obtained using the online databases ONCOMIR and TCGA.BRCA.sampleMap/miRNA HiSeq gene database.

RESULTS

Allelic and genotypic frequencies

The analysis of allelic and genotypic frequencies for each of the three SNPs showed no significant deviation (p < .01) from Hardy‐Weinberg equilibrium in Tunisian and Libyan populations (Appendix Table A). Allelic frequencies do vary across the North African populations. The allelic frequency of ancestral alleles at SNPs rs3869550, rs95797, and rs7211777 were higher in Kairouan, Kerkennah, and Mahdia populations than the alternate alleles. The opposite situation was observed in Kesra, Smar, Sousse, and Libyan populations (Table 1). Globally, average values in the North African populations were close to those of South Asian populations. For all three SNPs the Kesra show the strongest frequency differences with each of the other North African population samples.
TABLE 1

Allelic frequencies in North African populations at 3 SNPs (rs3869550, rs957971, rs7211777) of the STAT3 gene (2n= number of analyzed chromosomes, *ancestral reference allele)

SNP allelesKairouanKerkennahKesraMahdiaSmarSousseLibya
rs38695502n = 802n = 862n = 782n = 862n = 1162n = 862n = 118
C* 47 (0.59) 47 (0.55) 22 (0.29) 45 (0.52) 54 (0.47) 40 (0.47) 58 (0.49)
T 33 (0.41) 39 (0.45) 56 (0.71) 41 (0.48) 62 (0.53) 46 (0.53) 60 (0.51)
rs9579712n = 762n = 842n = 842n = 902n = 1222n = 922n = 134
C* 44 (0.58) 44 (0.52) 29 (0.35) 46 (0.51) 59 (0.48) 43 (0.47) 66 (0.49)
G 32 (0.42) 40 (0.48) 55 (0.65) 44 (0.49) 63 (0.52) 49 (0.53) 68 (0.51)
rs72117772n = 702n = 882n = 842n = 902n = 1242n = 922n = 140
G* 39 (0.56) 49 (0.56) 29 (0.35) 45 (0.5) 57 (0.46) 45 (0.49) 73 (0.52)
A 31 (0.44) 39 (0.44) 55 (0.65) 45 (0.5) 67 (0.54) 47 (0.51) 67 (0.48)
Allelic frequencies in North African populations at 3 SNPs (rs3869550, rs957971, rs7211777) of the STAT3 gene (2n= number of analyzed chromosomes, *ancestral reference allele) Allele frequencies among the three SNPs studied tend to be strongly correlated across populations around the world (Table S2: Supplementary Data).

Linkage disequilibrium

We compared the linkage disequilibrium (LD) structure of STAT3 SNP (rs3869550, rs957971, rs7211777) among the studied populations. Linkage disequilibrium among the three SNPs of the STAT3 gene in North African populations was also compared to European populations and African populations in Table 2 which illustrates r2 and D′ values for each pair of SNPs in these populations. Taken together, results revealed a strong linkage disequilibrium among the 3 SNPs. The lower value of D′ between rs3869550 and rs957971 was observed in the Kesra population which is the only population considered as Berber among the studied populations. We also noticed that the population of Mahdia displayed a total LD similar to European populations while the remaining North African populations studied presented similar LD to African populations.
TABLE 2

Linkage disequilibrium between pairs of the studied SNPs (rs3869550, rs957971, rs7211777) of the STAT3 gene in North African, African, and European populations

PopulationL1L2D′R2 Distance basepairs
Kairouanrs3869550rs9579711.01.027,038
rs3869550rs72117771.01.041,188
rs957971rs72117771.01.014,150
Kerkennahrs3869550rs9579711.01.027,038
rs3869550rs72117770.8920.75741,188
rs957971rs72117770.9440.7714,150
Kesrars3869550rs9579710.9350.87527,038
rs3869550rs72117770.9350.87541,188
rs957971rs72117770.9470.89714,150
Mahdiars3869550rs9579711.00.90727,038
rs3869550rs72117771.00.86441,188
rs957971rs72117771.00.95714,150
Smarrs3869550rs9579710.9630.89627,038
rs3869550rs72117770.9640.89741,188
rs957971rs72117771.00.93614,150
Soussers3869550rs9579711.00.95227,038
rs3869550rs72117770.9510.90541,188
rs957971rs72117771.00.91514,150
Libyars3869550rs9579711.00.93227,038
rs3869550rs72117770.9310.86641,188
rs957971rs72117771.00.94214,150
Africars3869550rs9579711.00.97627,038
rs3869550rs72117770.9930.86841,188
rs957971rs72117771.00.85914,150
Europers3869550rs9579711.00.99627,038
rs3869550rs72117771.00.99641,188
rs957971rs72117771.01.014,150
Linkage disequilibrium between pairs of the studied SNPs (rs3869550, rs957971, rs7211777) of the STAT3 gene in North African, African, and European populations Linkage disequilibrium is very strong among the 3 SNPs considered pairwise. In Table 2, the r2 measurements are in the range of 0.85 to 1.00. The high degree of similarity of the SNP frequencies can be seen visually in supplementary Figure (SF1) or by inspecting the SNP frequencies in supplementary Table S2. Overall, the LD is very high and the deviations from complete (D′ = 1.0) LD is attributable to rare haplotypes (Figure 3).
FIGURE 3

STAT3 haplotype frequency estimates based on 3 SNPs in 92 populations

STAT3 haplotype frequency estimates based on 3 SNPs in 92 populations

Analysis of haplotype frequencies

The three STAT3 SNPs can occur in eight possible combinations. Direct gene counting evidence supports the occurrence of all eight haplotypes among the populations sampled from around the world. As shown in Figure 3 and Table S3 (Supplementary Data), there are, in the 92 populations (>5600 individuals) studied, two haplotype alleles CCG, the ancestral allele, and TGA, the fully derived allele, that occur at very common frequencies worldwide. The other six haplotypes usually occur at low to rare frequencies (<5%) but in some populations, they do occur at moderately common frequencies (5%–21%). The ancestral allele occurs at the highest frequencies (often at 80%–90%) in sub‐Saharan Africa and in some populations in the Pacific region. The fully derived allele is found at very common frequencies (>90%) in Native American populations. In other world regions (North Africa, Europe, and Asia) the TGA and CCG haplotypes both occur at very common frequencies with TGA usually being the more frequent allele. In Figure 4, a Network summarizes this relationship between the haplotypes constructed by these three SNPs of the STAT3 gene.
FIGURE 4

Network of the relationship between the haplotypes constructed by the three SNPs (rs7211777, rs957971, rs3869550) of the STAT3 gene

Network of the relationship between the haplotypes constructed by the three SNPs (rs7211777, rs957971, rs3869550) of the STAT3 gene Considering the functional aspects of the studied SNPs that are located at the intronic level, we hypothesized that sites containing these SNPs could be the target of microRNAs with a possible effect on the splicing or stability of STAT3 mRNA. So, we sifted the databases for possible miRs that could target these regions at the level of human STAT3 gene. No target miR was identified for rs3869550 and rs957971, but the derived allele of rs7211777 was targeted by a miR centric hsa‐miR‐3606‐5p when G is replaced by A with a score of 65 which can be significant (Figure 5).
FIGURE 5

The mutated sequence at rs7211777 targeted by mir‐3606‐5p

The mutated sequence at rs7211777 targeted by mir‐3606‐5p

DISCUSSION

STATs are ligand‐induced transcriptional factors that are activated in response to a wide range of cytokines, growth factors, and hormones. STAT3 is constitutively activated in various cancers including breast cancer. The association of STAT3 polymorphism and cancer in the Tunisian population is still unknown. The importance of this transcription factor and its involvement in various biological processes and different types of pathologies justifies its attention from the point of view of its activity, which is often a function of genetic polymorphism. STAT3 SNP data in human populations show frequency differences that need to be clarified especially for North African populations on which little data is available. Our results on the genetic diversity of STAT3, considering 3 SNPs associated with cancer in populations, show the distinctiveness of Sub‐Saharan Africans and Native American populations from each other and from populations in other world regions. Although there is very strong linkage disequilibrium present among these STAT3 SNPs in the many populations examined, the allele and haplotype frequency levels do vary around the world. Two of the eight possible haplotypes (the ancestral CCG and the fully derived TGA) are observed to occur at predominant frequencies in the 92 populations studied. This could have arisen by random genetic drift or it could be related to positive selection but studies differentiating among these possibilities have not yet been carried out. However, to the extent that beneficial or harmful genetic variants for the development of various types of cancers or for the response to therapeutic interventions exist in linkage disequilibrium with these observed haplotypes, it is clear from the genetic variation demonstrated in this report that we should expect that population differences will be observed. Our results on the genetic diversity of STAT3 showed a high level of diversity in North African populations with seven haplotypes observed. In the PCA plot, North African populations resemble South Asians populations and occupy an intermediate position between Sub‐Saharan African and the rest of worldwide populations, with a particular behavior of Berber population from Kesra which was close to Europeans, and the island of Kerkennah population which was isolated (Supplementary Figure SF2). This feature seems to be related to the presence of rare STAT3 haplotypes such CCA and TCA which were specific to North African populations. Two rare haplotypes CGG and TGG could have been generated from the ancestral haplotype CCG by point mutation or recombination, then the four others (CGA, TCG, CCA, TCA) could be mostly obtained by recombination between the two major haplotypes (CCG and TGA), excepted for TCA haplotype that could have been generated by recombination between the two rare haplotypes (Figure 6). One has to ask for the cause of such haplotype diversity in North‐African populations. Since the two major haplotypes are present in all human populations, heterozygous genotypes CCG/TGA could lead to the possibility of recombination.
FIGURE 6

(a) Haplotype generated by point mutation, (b) Haplotypes generated by combination

(a) Haplotype generated by point mutation, (b) Haplotypes generated by combination Moreover, the presence of recombinant specific haplotypes seems to be characteristic of the North African populations studied. This has been reported for other genes, such as BRCA1, in Tunisian breast cancer patients that displayed several distinct SNP haplotypes, corresponding to different evolution forms, which were less numerous than haplotypes observed in US patients (Troudi et al., 2007). In fact, the American melting pot is recent compared to the very ancient admixture that occurred in North Africa and shown by genetic analysis of actual populations (Ennafaa et al., 2011; Frigi et al., 2010) and also genome analysis of Neolithic fossils (Fregel et al., 2018). Indeed, according to these studies, four components of diverse origins (Sub‐Saharan, European, Middle Eastern, and North‐African) have been found to be present in North African genomes since at least the Neolithic period. This high level of admixture from prehistoric times should have given possibilities for recombination between distinct haplotypes, leading to new combinations. These conditions may not have been met in other ancient human communities, whose low numbers would have generated a tendency to consanguinity and homozygosity. Considering the pleiotropic role of STAT3 as a transcription factor particularly involved in inflammation and immune response on one hand and the impact of the studied SNPs at the functional level, we can argue that positive selection should have played a role out of Africa, when human migrants settled in a new infectious environment toward which their immune system had to adapt. One has to ask how the location of these SNPs in STAT3 introns might impact the function of the protein. Analysis performed using micro‐RNA databases allowed to assess the possibility of targeting these SNPs regions by specific miR. Our results showed the STAT3 region with the derived allele of rs7211777 (G>A) was targeted by miR hsa‐miR‐3606‐5p. The previous study of STAT3 polymorphism rs3869550 of Jiang et al. conducted on (NSCLC) non‐small cell lung cancer showed that the STAT3 protective haplotype GCGGC contains the ancestral allele (G) instead of the derived allele A (Jiang et al., 2011). Analysis of haplotypes deduced by Vaclavicek et al (Vaclavicek et al., 2007) that the rare haplotype CGCC which contained the derived allele from each SNP (STAT3 rs721177 and STAT5B rs6503691), was associated with an increased risk of Breast Cancer (OR = 5.83, 95% CI 1.51–26.28, p = .002). Interestingly, several genes are targeted by miR‐3606‐5p in breast cancer according to ONCOMIR (Table 3). Expression of hsa‐miR‐3606‐5p has been quantified in normal and breast cancer tissues (TCGA.BRCA.sampleMap/miRNA HiSeq gene database). According to these results, miR‐3606‐5p might explain the association of rs7211777 at STAT3 gene with Breast cancer. This hypothesis should be confirmed particularly in North African populations where the risk allele (A) is associated with different STAT3 haplotypes and also by assessment of STAT3 mRNA expression and mir‐3606‐5p in normal and pathological conditions along with STAT3 SNP genotype.
TABLE 3

Targeted genes by miR‐3606‐5p in breast cancer (BRCA type) according to ONCOMIR

GeneGene DescriptionCorrelationCorrelation P‐valueCorrelation FDRmiRDB Score
MKL2MKL/myocardin‐like 2−0.08241.65e‐029.46e‐0153
RMND1required for meiotic nuclear division 1 homolog (S. cerevisiae)−0.08221.69e‐029.46e‐0183
NFAT5nuclear factor of activated T‐cells 5, tonicity‐responsive−0.07632.65e‐029.46e‐0173
MEF2DMyocyte Enhancer factor 2D−0.07293.41e‐029.46e‐0190
EDNRBEndothelin Receptor type B−0.07203.64e‐029.46e‐0158
MED12LMediator complex subunit 12‐like−0.06974.28e‐029.46e‐0160
Targeted genes by miR‐3606‐5p in breast cancer (BRCA type) according to ONCOMIR Moreover, miR‐3606‐5p is not the only one that regulates STAT3, it is also regulated by other miRs. For example, Mir‐520 blocks the progression of EMT by targeting STAT3, in addition, mir‐544 inhibits Bcl6 and STAT3 in parallel to decrease cell growth in TNBC (Wang et al., 2017; Zhu et al., 2016). Moreover, rs7211777, as located in intron 1, is close to exon 1 and the promoter region. Indeed, the investigation about LD with two other common SNPs in the STAT3 promoter region (rs 3736164, rs4796793) revealed a strong linkage disequilibrium among the 3 SNPs in worldwide populations (LD Supplementary Data). Table 4 illustrates r2 and D′ values for each pair of SNPs. Hence this strong LD does not exclude that another mechanism could be associated with the regulation of STAT3 haplotypes expression at the transcriptional level due to functional variants affecting the promoter region of the gene. Indeed, the rs4796793 SNP was previously shown to be associated with cervical cancer, women with a G allele at rs4769793 being submitted to a higher risk for cervical cancer (K. Wang et al., 2011).
TABLE 4

Linkage disequilibrium between pairs of the SNPs (rs3869550, rs957971, rs7211777, rs3736164, rs4796793) of the STAT3 gene worldwide populations

All populations
Rs numberrs3869550rs957971rs7211777rs3736164rs4796793
D′
rs38695501.00.9990.9831.00.996
rs9579710.9991.01.01.00.996
rs72117770.9831.01.01.00.996
rs37361641.01.01.01.00.996
rs47967930.9960.9960.9960.9961.0
R2
rs38695501.00.980.960.6230.557
rs9579710.981.00.9760.6350.567
rs72117770.960.9761.00.6190.553
rs37361640.6230.6350.6191.00.894
rs47967930.5570.5670.5530.8941.0
Linkage disequilibrium between pairs of the SNPs (rs3869550, rs957971, rs7211777, rs3736164, rs4796793) of the STAT3 gene worldwide populations In conclusion, previous research has shown that polymorphisms at the STAT3 gene appear to have functional effects on the development and pathological course of various cancers. Assessment of such effects should be investigated in North African populations, considering the presence of specific recombinant STAT3 haplotypes.

CONFLICT OF INTEREST

The authors declared no conflict of interest. Supplementary Material Click here for additional data file. Appendix A Click here for additional data file.
  46 in total

1.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

2.  Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling.

Authors:  Anne Schroeder; Andreas Herrmann; Gregory Cherryholmes; Claudia Kowolik; Ralf Buettner; Sumanta Pal; Hua Yu; Gerhard Müller-Newen; Richard Jove
Journal:  Cancer Res       Date:  2013-10-31       Impact factor: 12.701

3.  Contribution of JAK2 and STAT3 variants to the genetic susceptibility of recurrent miscarriage among Bahraini and Tunisian Arabs.

Authors:  Safia Messoudi; Manar A Al-Sulaiti; Amna S Al-Busaidi; Maryam Dendana; Brahim Nsiri; Wassim Y Almawi; Touhami Mahjoub
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

4.  HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes.

Authors:  M E Hawley; K K Kidd
Journal:  J Hered       Date:  1995 Sep-Oct       Impact factor: 2.645

5.  An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis.

Authors:  Maria Hatziapostolou; Christos Polytarchou; Eleni Aggelidou; Alexandra Drakaki; George A Poultsides; Savina A Jaeger; Hisanobu Ogata; Michael Karin; Kevin Struhl; Margarita Hadzopoulou-Cladaras; Dimitrios Iliopoulos
Journal:  Cell       Date:  2011-12-09       Impact factor: 41.582

6.  Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.

Authors:  Joshua D Milner; Tiphanie P Vogel; Lisa Forbes; Chi A Ma; Asbjørg Stray-Pedersen; Julie E Niemela; Jonathan J Lyons; Karin R Engelhardt; Yu Zhang; Nermina Topcagic; Elisha D O Roberson; Helen Matthews; James W Verbsky; Trivikram Dasu; Alexander Vargas-Hernandez; Nidhy Varghese; Kenneth L McClain; Lina B Karam; Karen Nahmod; George Makedonas; Emily M Mace; Hanne S Sorte; Gøri Perminow; V Koneti Rao; Michael P O'Connell; Susan Price; Helen C Su; Morgan Butrick; Joshua McElwee; Jason D Hughes; Joseph Willet; David Swan; Yaobo Xu; Mauro Santibanez-Koref; Voytek Slowik; Darrell L Dinwiddie; Christina E Ciaccio; Carol J Saunders; Seth Septer; Stephen F Kingsmore; Andrew J White; Andrew J Cant; Sophie Hambleton; Megan A Cooper
Journal:  Blood       Date:  2014-10-30       Impact factor: 22.113

7.  Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations.

Authors:  Mariana Gutiérrez; Paula Scaglia; Ana Keselman; Lucía Martucci; Liliana Karabatas; Sabina Domené; Ayelen Martin; Patricia Pennisi; Miguel Blanco; Nora Sanguineti; Liliana Bezrodnik; Daniela Di Giovanni; María Soledad Caldirola; María Esnaola Azcoiti; María Isabel Gaillard; Lee A Denson; Kejian Zhang; Ammar Husami; Nana-Hawa Yayah Jones; Vivian Hwa; Santiago Revale; Martín Vázquez; Héctor Jasper; Ashish Kumar; Horacio Domené
Journal:  Mol Cell Endocrinol       Date:  2018-02-03       Impact factor: 4.102

8.  STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.

Authors:  Jennifer Permuth-Wey; William J Fulp; Brett M Reid; Zhihua Chen; Christina Georgeades; Jin Q Cheng; Anthony Magliocco; Dung-Tsa Chen; Johnathan M Lancaster
Journal:  Int J Cancer       Date:  2015-08-28       Impact factor: 7.396

9.  miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers.

Authors:  Liqin Du; Maria C Subauste; Christopher DeSevo; Zhenze Zhao; Michael Baker; Robert Borkowski; Jeoffrey J Schageman; Rachel Greer; Chin-Rang Yang; Milind Suraokar; Ignacio I Wistuba; Adi F Gazdar; John D Minna; Alexander Pertsemlidis
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

10.  STAT3 polymorphisms in North Africa and its implication in breast cancer.

Authors:  Wafa Ziadi; Sami Boussetta; Sarra Elkamel; Andrew J Pakstis; Kenneth K Kidd; Imen Medimegh; Amel Ben Ammar Elgaaied; Lotfi Cherni
Journal:  Mol Genet Genomic Med       Date:  2021-07-12       Impact factor: 2.183

View more
  1 in total

1.  STAT3 polymorphisms in North Africa and its implication in breast cancer.

Authors:  Wafa Ziadi; Sami Boussetta; Sarra Elkamel; Andrew J Pakstis; Kenneth K Kidd; Imen Medimegh; Amel Ben Ammar Elgaaied; Lotfi Cherni
Journal:  Mol Genet Genomic Med       Date:  2021-07-12       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.